Spread the Word 📣

Help this story reach more people by sharing it with your social network.

Choose a platform, pick a pre-written post, customize it if you'd like, and click Share.

Filter

Arkayli Biopharma, Inc. is sharing an important update: “Arkayli Biopharma Inc. Receives Study May Proceed Response to IND from FDA and SBIR Grant from NIH to Advance Clinical Development of ARK001 for a Rare Pediatric Disease“. Read the full release below:

Press Release from PR Newswire www.prnewswire.com

Select social network:

Platforms